APPLICATION
ANDA200898
TYPE
ANDA
ORIGINAL APPROVAL
2014-07-28
LATEST ACTION
2025-06-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
EXEMESTANEDiscontinued
EXEMESTANE 25MG · TABLET · ORAL
Approval history
2025-06-16Labeling · Supplement 13 · standardAP
2023-05-23Labeling · Supplement 12 · standardAP
2019-02-22Labeling · Supplement 6 · standardAP
2019-02-22Labeling · Supplement 10 · standardAP
2014-07-28UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.